GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$90.18
+2.72% today
Updated 2026-04-30
Market cap
$11.91B
P/E ratio
22.40
P/S ratio
4.05x
EPS (TTM)
$3.92
Dividend yield
—
52W range
$52 – $101
Volume
1.1M
WallStSmart proprietary scores
72
out of 100
Grade: B
Buy
Investment rating
9.3
Growth
A+7.8
Quality
B+7.0
Profitability
B+6.7
Valuation
B4/9
Piotroski F-Score
Moderate
3.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$110.64
+22.69%
12-Month target
$90.01
-0.19%
Intrinsic (DCF)
$149.54
Margin of safety
+40.98%
4 Strong Buy6 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 3.88 — safe zone
+ Free cash flow $192.39M — positive
+ Revenue growth 25.70% QoQ
+ 40.98% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.02B | $1.57B | $2.52B | $2.94B | $2.94B |
| Net income | $190.17M | $122.87M | $102.98M | $537.90M | $140.63M |
| EPS | — | — | — | — | $3.92 |
| Free cash flow | $104.42M | $165.22M | $405.21M | $588.77M | $192.39M |
| Profit margin | 18.59% | 7.83% | 4.09% | 18.30% | 18.30% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-25 | HULLER, KELLY | Sale | 20,000 | — |
| 2026-02-25 | HULLER, KELLY | Buy | 20,000 | $43.58 |
| 2026-02-12 | HULLER, KELLY | Sale | 10,000 | — |
Peer comparison
Smart narrative
Globus Medical trades at $90.18. representing a P/E of 22.40x trailing earnings. Our Smart Value Score of 72/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 3.88, it sits in the safe zone. TTM revenue stands at $2.94B. with profit margins at 18.30%. Our DCF model estimates intrinsic value at $149.54.
Frequently asked questions
What is Globus Medical's stock price?
Globus Medical (GMED) trades at $90.18.
Is Globus Medical overvalued?
Smart Value Score 72/100 (Grade B, Buy). DCF value $149.54.
What is the price target of Globus Medical (GMED)?
The analyst target price is $110.64, representing +22.7% upside from the current price of $90.18.
What is the intrinsic value of Globus Medical (GMED)?
Based on our DCF model, intrinsic value is $149.54, a +41.0% margin of safety versus $90.18.
What is Globus Medical's revenue?
TTM revenue is $2.94B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
3.88 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio4.05x
ROE12.30%
Beta1.09
50D MA$90.16
200D MA$76.71
Shares out0.11B
Float0.11B
Short ratio—
Avg volume1.1M
Performance
1 week-6.98%
1 month+1.89%
3 months-2.69%
YTD+0.55%
1 year—
3 years—
5 years—